Skip to main content

JANE STREET GROUP, LLC

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 1595888 NEW YORK, NY

Position in ARQT

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$6,682,157
+$251,947 QoQ
Shares Held
283,623
+28.1% QoQ
Ownership
0.227%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
16 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ARQT Over Time

Shares Held

Position Value (USD)

Derivatives in ARQT

reported options exposure · as of Mar 31, 2026
CallValue
$3,105,208
CallShares
131,800
PutValue
$1,057,844
PutShares
44,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $1,247,243,084 across 314 Biotechnology names. ARQT ranks #38 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ARQT

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,105,208 131,800
2026-03-31 $1,057,844 44,900
2026-03-31 $6,682,157 283,623
2025-12-31 $2,840,112 97,800
2025-12-31 $6,430,210 221,426
2025-12-31 $203,280 7,000
2025-09-30 $891,605 47,300
2025-09-30 $6,800,513 360,770
2025-09-30 $265,785 14,100
2025-06-30 $740,256 52,800
2025-06-30 $1,782,249 127,122
2025-03-31 $451,996 28,900
2025-03-31 $408,204 26,100
2025-03-31 $1,821,684 116,476
2024-12-31 $663,068 47,600
2024-12-31 $1,468,792 105,441
2024-12-31 $759,185 54,500
2024-09-30 $1,032,968 111,072
2024-09-30 $585,900 63,000
2024-06-30 $1,395,976 150,105
2024-03-31 $2,116,140 213,536
2023-12-31 $518,740 160,601
2023-09-30 $653,262 123,025
2023-06-30 $1,456,440 152,827
2023-03-31 $288,805 26,255
2022-09-30 $364,637 19,081
2022-03-31 $277,305 14,398
2020-09-30 $321,098 10,959